The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InFICO reported robust financial results for its second fiscal quarter ended March 31, 2026, posting earnings of $11.14 per share and a net income of $264.5 million. Adding to the corporate earnings calendar, medical technology firm HeartBeam announced it will host a conference call on May 13, 2026, to discuss Q1 results and strategic growth initiatives. HeartBeam is currently focusing on AI-driven programs and developing specialized technologies for heart attack detection and 3D ECG synthesis. Meanwhile, other firms including ATRO, LMRI, and FSCO have also finalized their earnings schedules for the period. FICO's significant growth highlights strong profitability margins, while HeartBeam's upcoming update underscores the increasing role of AI in healthcare. Investors remain focused on these upcoming disclosures to gauge broader market momentum and technological advancement.